Browse > Article

Clinical Significance of the Expression of c-Met in Thyroid Tumor  

Rho Young-Soo (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Hwang Joon-Sik (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Kim Jin-Hwan (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Lim Young-Han (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Kim Seung-Tae (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Cho Seong-Jin (Department of Pathology, College of Medicine, Hallym University)
Publication Information
Korean Journal of Head & Neck Oncology / v.21, no.1, 2005 , pp. 15-20 More about this Journal
Abstract
Objectives: The hepatocyte growth factor(HGF)/c-Met pathway may play various roles in the carcinogenesis of various organs. Although HGF/c-Met signalling pathway has been shown to demonstrate various cellular responses including mitogenic, proliferative, morphogenic and angiogenic activities, the study on their expression related to clinicopathological parameters in thyroid tumor is relatively rare. So we want to find out the clinical significance of the c-Met in thyroid tumor. Materials and Methods: We assess the mRNA and protein expression of the c-Met genes by means of RT-PCR method and the immunohistochemical stain in 100 cases of thyroid tumors(50 papillary carcinomas, 10 follicular carcinomas, 20 follicular adenomas, 20 nodular hyperplasia). Results: By RT-PCR, c-Met mRNA was detected in 43(86%) in papillary carcinoma, 4(40%) in follicular carcinoma, 4(20%) in follicular adenoma and 2(10%) in nodular hyperplasia cases. By immunohistochemistry, c-Met protein expression was detected in 44(88%), 2(20%), 3(15%) and 1(5%). Expression of the c-Met mRNA and protein expression was significantly highly recognized in papillary carcinoma. The c-Met protein overexpression was significantly correlated with the grade of the differentiation. Conclusion: These results suggest that c-Met expression may be associated with thyroid papillary cancer progression. The differential expression of c-Met protein and mRNA suggests that these molecules may be a reliable diagnostic marker in thyroid papillary cancer.
Keywords
Thyroid tumor; c-Met;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Maeta H, Ohgi S, Terada T: Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch. 2001;438(2):121-128   DOI   ScienceOn
2 Boix L, Rosa JL, Ventura F, et al: c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology. 1994;1:88-91   DOI
3 Rosen EM, Meromasky L, Setter E: Purified scatter factor stimulates epithelial and endothelial cell migration. Proc Soc Exp Biol Med. 1990;195:34-43   DOI
4 Lppolito A, Vella V. La Rossa GL: Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy. Thyroid. 2000;11(8):783-787   DOI   ScienceOn
5 Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R: Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002;13:41-59   DOI   ScienceOn
6 Ramirez R, Hsu D, Patel A: Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2000;53(5):635-644   DOI   ScienceOn
7 Rygaard K, Nakamura T, Spang-Thomsen M: Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer. 1993;67(1):37-46   DOI   ScienceOn
8 Fluge O, Haugen DR, Lillehaug JR, Varhaug JE: Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue. World J Surg. 2001;25:623-631   DOI   ScienceOn
9 Rueo LP, Stoppaeeaior A, Ballarini F, Prat M: Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol. 2001;194(1):4-8   DOI   ScienceOn
10 Saji M, Westra WH, Chen H, et al: Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery. 1997;122:1137-1140   DOI   ScienceOn